| Literature DB >> 33652881 |
Su-Min Baek1, Seoung-Woo Lee1, Tae-Un Kim1, Seong-Kyoon Choi2, Sungho Yun3, Won-Jae Lee3, Se-Hyeon Han1,4, Il-Hwa Hong5, Sang-Joon Park3, Tae-Hwan Kim1, Kyu-Shik Jeong1,6, Jin-Kyu Park1,6.
Abstract
Senescence marker protein 30 (SMP30) is a cell survival factor playing an important role in vitamin C synthesis and antiapoptosis. Moreover, its cytoprotective role suggests a possibility to be related to cancer cell survival. Mammary carcinoma is a common cancer in both humans and animals. Because of its histopathological diversity, especially in the early stage, histopathological diagnosis may be complicated; therefore, a diagnostic marker is helpful for confirmation. The present study analyzed the expression pattern of SMP30 in mammary carcinoma in humans, dogs, and cats. Immunohistochemistry, immunofluorescence, and western blot analysis were used to investigate SMP30 expression patterns. The expression was specifically observed in neoplastic glandular epithelial cells. The expression increased with the malignancy of glandular epithelial cells with a highly proliferative status. However, SMP30 expression was low in normal mammary gland tissues or well-differentiated adenoma tissues. The patterns were consistently reproduced in canine primary mammary carcinoma cells and MCF-7 and MDA-MB-231 human carcinoma cell lines. This study provides useful information to understand SMP30 expression in various stages of mammary carcinoma and to suggest its utility as a pan-species diagnostic marker, thereby helping to establish strategies for diagnosing mammary carcinoma in several species.Entities:
Keywords: SMP30; breast cancer; cat; diagnostic marker; dog; human; mammary carcinoma; neoplastic glandular epithelial cell
Mesh:
Substances:
Year: 2021 PMID: 33652881 PMCID: PMC7956281 DOI: 10.3390/ijms22052340
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923